PerkinElmer launches Operetta high content screening system
12 January 2009
PerkinElmer, Inc., has launched its Operetta system, a benchtop
instrument that provides high content screening (HCS) and high content
analysis (HCA) capabilities to drug discovery and cellular science
research laboratories.
Operetta is an HCS/HCA instrument platform that employs PerkinElmer’s
proprietary new Harmony software which provides researchers with easy to
use building blocks for creating user configurable workflows via simple
step-by-step procedures.
An extensive range of ready-made solutions for frequently used image
analysis tasks is pre-installed. Also installed is a scalable database
for image management, and data analysis or retrieval. The Harmony
software provides tools to develop high content assays, image analysis
storage and retrieval, as well as remote access capability.
“The Operetta platform and Harmony software extend PerkinElmer’s
portfolio in cellular imaging and bring the benefits of HCS and HCA to
almost any life sciences laboratory,” said Richard Eglen, PhD,
president, Bio-discovery, PerkinElmer. “Our expertise in cellular
imaging provides us with unique insights into common issues encountered
in implementing HCS research. We are now providing this critical
knowledge to Operetta users, so they can easily and rapidly optimize
imaging studies for their cell science research.”
The Operetta instrument is designed to allow maximum functionality in
the smallest possible footprint. A large field of view and
multi-processor technology facilitates high speed data acquisition and
analysis. A wide range of objectives and filters, bar-coded for
error-free operation, enables a wide range of assays and plates. This
compact design fits almost any size laboratory, allowing a flexible and
versatile solution to suit the needs of a cellular imaging research
facility.
Bookmark this page